The effect of saffron (Crocus sativus L.) hydro-alcoholic extract on liver and renal functions in type 2 diabetic patients: A double-blinded randomized and placebo control trial
Notes for this study:
|Values||Metabolic equivalents. Mean and SD. Placebo: before 942.33 ± 435.49, after 872.89 ± 341.42. Saffron: before 1193.80 ± 621.21, after 1181.50 ± 555.17.|
|Trial Design||Randomized trial|
|Trial Length||1-6 months|
|Number of Subjects||54|
In a randomized, double-blind, placebo-controlled trial, 54 participants with type 2 diabetes took 300 mg of saffron or placebo daily for 8 weeks.
There wasn't a statistically significant difference for BUN, creatinine, uric acid, liver enzymes or metabolic equivalents.
The trial was preregistered: IRCT2015082623776N1